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Alteration of defibrillation threshold by antiarrhythmic drugs:
a theoretical framework
Charles F. Babbs, M.D., M.S., Ph.D.
Biomedical Engineering Center, Purdue University, West Lafayette, Indiana, USA.
[Critical Care Medicine, Vol. 9, No.5, pp. 362-363, 1981]
Drugs may alter the ventricular defibrillation threshold, either to make resuscitation easier or
more difficult. Assuming that cardiac defibrillation is essentially large scale stimulation of nonrefractory areas in the fibrillating muscle mass [1], the action of cardiac drugs can be understood
theoretically in terms of their influence on the transmembrane sodium and potassium currents,
INa and I K. The magnitudes of these ionic currents are functions of the transmembrane potential,
Em, as shown in Figure 1(a).

FIG. l. Balance of inward sodium and outward potassium currents in ventricular cells
during diastole. (a) Absolute values of sodium and potassium currents as a function of
transmembrane potential. (b) Effects of alterations in membrane potential by electrical
stimuli.
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Here gNa and gK denote sodium and potassium conductances of the membrane, and E Na and EK
denote Nernst equilibrium potentials. The solid curve denoting sodium current is concave
upwards because of the voltage dependence of fast sodium channels.
Depolarization itself induces a sudden increase in gNa; while at this stage of the cardiac cycle, g K
is essentially constant. The sodium and potassium current curves, therefore, cross at two points
where inward sodium current and outward potassium current are equal. One point represents a
stable equilibrium--the resting membrane potential, E r. The other is an unstable equilibrium--the
cellular firing threshold, Eth. These two points divide the transmembrane potential domain into
three zones, labeled 1, 2, and 3 in Figure l(a).
The intensity of the electrical stimulus required to excite the ventricular muscle cell is related to
the width of zone 2. As illustrated in Figure 1(b), if E m is transiently driven into either zone 1 or
zone 2, it will return to the stable equilibrium value, Er, driven by the net ionic current. However,
if Em is driven past the cellular firing threshold into zone 3, an action potential will be initiated
and the cell will become refractory. The intensity of the stimulus required to excite the cell in
this way depends upon the extent of zone 2.
In theory, drugs that increase gK or decrease gNa will widen zone 2 (Eth  Er) and so increase the
strength of the stimulus required for excitation. In turn, these drugs will increase the
defibrillation threshold. Drugs that decrease gK or increase gNa will narrow zone 2 and reduce the
defibrillation threshold.
The authors have studied a variety of antiarrhythmic drugs to determine their effect on
ventricular defibrillation threshold in dogs. Drugs that decrease sodium conductance, such as
quinidine, or that increase potassium conductance, such as lidocaine, raise the defibrillation
threshold [2]. The new antifibrillatory drug, cloftlium (LY 150387), which decreases potassium
conductance and prolongs the action potential duration, in fact lowers defibrillation threshold, as
predicted from theory. Digitalis glycosides, which act by inhibiting the membrane bound
sodium-potassium "pump" and reduce the net outward sodium current, also lower the
defibrillation threshold.
One final ionic mechanism should be mentioned. Shift of the potassium equilibrium potential.
EK depends upon the (log Ko/Ki), where Ko and Ki represent extracellular and intracellular
potassium concentrations. Moderate elevation of extracellular potassium concentration makes E K
less negative, shifting the dashed line for potassium current in Figure l(a) to the right without
changing its slope. This effect decreases the extent of zone 2 and increases excitability. Infusion
of potassium chloride in dogs is known to lower defibrillation threshold, and at a critical level of
Ko spontaneous defibrillation occurs [5]. Extremely high levels of Ko, which cause a shift of the
potassium current line completely to the right of the sodium current curve, make the cell
inexcitable, because a normal resting potential cannot be restored. This last state may exist
during the use of "cardioplegic" solutions to immobilize the heart at surgery.
A summary of results from animal studies of ventricular defibrillation is given in Table 1.
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Table 1

Evidently, the actions of cardiac drugs on the defibrillation threshold can be understood in terms
of basic electrophysiology. In practice, classical antiarrhythmic drugs do not reduce the
defibrillation threshold and should not be given for this purpose. Potassium doses lower
threshold but also produces an unwanted negative inotropic effect. Digitalis lowers threshold, but
only at toxic doses. Newer agents, such as clofilium, which act by other than a local anesthetic
mechanism, may have the dual advantage of reducing defibrillation threshold while preventing
recurrent episodes of fibrillation. Such drugs may offer a special theoretical advantage for the
hospitalized patient with recurrent ventricular fibrillation and may even be of value when
administered during advanced life support.
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